#safety — Sunday, February 01, 2026 (2 items)
| 0 | 💬 0 |
Live-attenuated chikungunya vaccine in children: a randomized phase 2 trial.
(nature.com)
|
Nature Medicine 2026-02-01 | #vaccination #clinical trial #immunogenicity #safety #chikungunya | |
| 0 | 💬 0 |
Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.
(nature.com)
|
Nature Medicine 2026-02-01 | #clinical trial #gene therapy #safety #spinal muscular atrophy |